health
Her son was dying, but his rare cancer made it difficult to get the right drug
As knowledge about genetics advances, some doctors say cancers should be defined by their mutations, not the tissues where they manifest.
Eighteen months after his initial diagnosis, chemotherapy hadn't slowed 21-year-old Mason Henderson's rare brain tumor, which had spread to his spinal fluid. So he left his home in southeastern Texas to spend three weeks in a clinical trial in New Yo... [11816 chars]
Read Full ArticleShare this story
Up next
Related Stories
Moody? Aggressive? You could have ‘irritable male syndrome’
New York Post
Ozempic and Wegovy linked to brain health risks from caloric cuts
Fox News
After 20 Miscarriages, Mom Celebrates Son’s First Birthday: ‘I Couldn’t Give Up’ (Exclusive)
Yahoo
5 Georgia siblings diagnosed with measles
WSB-TV
People Who Drink Their Own Pee Are Obsessed With AI, Using It to Reassure Themselves That It's a Miraculous Cure-All
Futurism